Menu ×


Cell Line Development Services Market Segmentation By Product (Reagents & Media, Equipment); By Source (Mammalian, Non-Mammalian); By Type (Recombinant Cell Lines, Hybridomas, Continuous Cell Lines, Primary Cell Lines); By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering) – Global Demand Analysis & Opportunity Outlook 2027

  • Report ID: 713
  • Text Size:

Extensive insights into the Growth of Cell Line Development Services Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights

Global Cell Line Development Services Market Overview

Cell is the basic unit of life; cell line is the culture developed from a single cell. It is developed in the lab under natural conditions where cell can nurture and multiply indefinitely. The cell line growth requires different nutrients and growth factors.

Cell line is one of the key tools used in research for studying the physiology and biochemistry of cells, the effects of drugs and toxic compounds on the cells, drug screening and development to produce biological compounds. Cell lines are subculture of primary culture also known as sub-clone. These are derived from primary cultures and have a limited life span, after subsequent cultures, cells with the highest growth capacity dominate which are selected for further cell development. Primary cells are ones that are cultured directly from a subject and have a limited lifecycle. A preserved cell line can multiply for an indefinite period either through random mutation or else by deliberate modification which are useful especially for creation of therapeutics.

Cell lines are essential for a wide range of applications including gene function studies, drug discovery assays, the production of biotherapeutics and diagnostics. The application of cell lines lies in research, bioproduction and diagnostics. Among research, cell lines are used for studying disease, screening, cell-based assays are used during discovery phase and preclinical development. Cell lines are consumed to manufacture a wide range of biotherapeutics comprising of vaccine, recombinant proteins that includes peptides, cytokines, hormones and clotting factors, enzymes and monoclonal antibodies.

Market Size and Forecast

Cell line development services market is expected to witness strong growth owing to growing adoption of regenerative medicine, healthcare expenditure levels and increase in investments in the biotechnology industry. Global cell line development services market is expected to record a CAGR of 17% over the forecast period and is estimated to reach a value of USD 1.5 billion at the end of the forecast period.

The market is segmented by product (reagents & media, equipment; by source (mammalian, non-mammalian); by type (recombinant cell lines, hybridomas, continuous cell lines, primary cell lines); by application (bioproduction, drug discovery, toxicity testing, tissue engineering). Reagents and media accounted for the largest revenue share on account of increasing bioproduction that needs these products from incubation to preservation. These products are cost-intensive in nature and have repetitive use in bioproduction. Equipment used are incubators, bioreactors, storage equipment, centrifuge, and microscopes, out of which, bioreactors hold a dominant share owing to its usage in large-scale manufacturing of biologics. The market is expected to witness a rise in acceptance of a mammalian source for the monoclonal antibodies production and ability to express complex proteins like that of human beings. Primary cell culture is the fastest growing segment owing to its widespread application in genetics, cell morphology, cell metabolism, and physiology. CLICK TO DOWNLOAD FREE SAMPLE

Cell Line Development Services Market Graph

Growth Drivers

Technological advancement in cell line development market

The cell line technology is widely used in research and biotechnology industry. Advancement in biotechnology industry across the globe has led to development in cell culture, drug discovery and gene therapy. Technological improvements in development, manufacturing, screening technologies and assays possess immense growth opportunity for the market. Government initiatives for improving healthcare sector boosting the growth of the industry.


The complexities in development of stable cell lines and high risk of contamination owing to complex purification methods are restraining the market. Furthermore, lack of clear regulatory guidelines and high cost and technical requirement to adhere with accreditations are posing threat to the industry. Some other issues pertaining to stem cell research might hamper the business growth.

Market Segmentation

Our-in depth analysis of the cell line development services market includes the following segments:

By Product

  • Reagents & media
  • Equipment

By Source

  • Mammalian
  • Non-mammalian

By Type

  • Recombinant cell lines
  • Hybridomas
  • Continuous cell lines
  • Primary cell lines

By Application

  • Bioproduction
  • Drug discovery
  • Toxicity testing
  • Tissue engineering

By Region

On the basis of regional analysis, the global cell line development market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

North America cell line development services market accounted for the largest revenue share owing to higher incidences of infectious diseases and lifestyle disorders, coupled with geriatric population. Adoption of superior technologies for generating robust and highly productive cell lines for large scale therapeutic production, further accelerates the regional growth. Initiatives conducted by research organizations functioning such as Thermo Fisher Scientific Inc., American Type Culture Collection (ATCC), and Sigma-Aldrich Corporation which provide high-quality biologics services is attributing toward the progress. In addition, growing awareness pertaining to monoclonal antibodies application in cancer treatment is expected to drive the regional industry growth.

Asia Pacific reflected the greatest potential for growth regionally, with rapidly developing economies such as India and China leading the market. Additionally, rising disease burden including cancer, adoption of advanced cell line development techniques in biopharmaceutical industries, increasing patient demand for advanced biological drugs owing to growing healthcare affordability is boosting the regional growth. For instance, in India, organizations such as Department of Science and Technology (DST), Department of Scientific & Industrial Research (DSIR) and Department of Biotechnology (DBT) are regulating the production and guidelines for biotechnology products. These organizations specify guidelines pertaining to production or transfer technology, raises capital, and manpower requirements.

The cell line development market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating the Market

  • Lonza Group AG
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • Merck KGaA
  • Selexis S.A.
  • Rentschler Biopharma SE
  • Horizon Discovery Group Plc.
  • WuXi AppTec Group
  • Boehringer Ingelheim International GmbH
  • MabPlex Inc.
  • Catalent, Inc.

Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved